USS Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.82M Buy
37,217
+3,001
+9% +$553K 0.03% 309
2025
Q4
$6.02M Buy
34,216
+2,346
+7% +$383K 0.03% 329
2025
Q3
$4.46M Hold
31,870
0.02% 377
2025
Q2
$4M Buy
31,870
+372
+1% +$46.4K 0.02% 392
2025
Q1
$4.31M Hold
31,498
0.03% 358
2024
Q4
$4.82M Sell
31,498
-5,584
-15% -$942K 0.03% 384
2024
Q3
$7.18M Buy
37,082
+1,340
+4% +$280K 0.05% 322
2024
Q2
$8.3M Buy
35,742
+1,386
+4% +$301K 0.07% 250
2024
Q1
$7.41M Buy
34,356
+4,137
+14% +$969K 0.06% 272
2023
Q4
$7.82M Hold
30,219
0.07% 243
2023
Q3
$7.77M Buy
30,219
+1,719
+6% +$460K 0.08% 239
2023
Q2
$8.12M Hold
28,500
0.1% 230
2023
Q1
$7.93M Buy
28,500
+444
+2% +$123K 0.11% 218
2022
Q4
$7.77M Hold
28,056
0.11% 211
2022
Q3
$7.49M Sell
28,056
-8,292
-23% -$1.76M 0.11% 199
2022
Q2
$7.42M Sell
36,348
-2,732
-7% -$558K 0.07% 278
2022
Q1
$8.23M Buy
39,080
+5,437
+16% +$1.18M 0.07% 310
2021
Q4
$8.07M Hold
33,643
0.06% 321
2021
Q3
$9.52M Buy
33,643
+6,168
+22% +$2.02M 0.08% 260
2021
Q2
$9.52M Hold
27,475
0.08% 171
2021
Q1
$7.69M Hold
27,475
0.07% 189
2020
Q4
$6.72M Sell
27,475
-7,100
-21% -$1.83M 0.06% 193
2020
Q3
$9.8M Hold
34,575
0.09% 141
2020
Q2
$9.24M Buy
34,575
+4,797
+16% +$1.44M 0.1% 142
2020
Q1
$9.42M Buy
29,778
+22,678
+319% +$6.88M 0.13% 118
2019
Q4
$2.11M Buy
+7,100
New +$1.97M 0.02% 149

Other funds holding BIIB